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ABSTRACT: Prescription drug coverage became available under Medicare for the first time in 
2006 under Medicare Part D—the most significant change in government health care programs in 
40 years. While it offers the potential for improved access to needed medications for millions of 
Americans, Part D has had both successes and challenges. With the program now in its second 
year, researchers have the opportunity to learn from experiences and strengthen the program, 
particularly as it affects the frailest, sickest, and most vulnerable beneficiaries. Although 13.2 million 
beneficiaries are eligible for a low-income subsidy to help pay for premiums and medication 
copayments, 3.3 million of this group are not enrolled in Part D and not receiving the subsidy. 
This report discusses some of the challenges vulnerable Medicare beneficiaries face in using Part D 
and makes specific recommendations, like using simpler, more standard procedures and ensuring 
that needed counseling support is provided. 
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EXECUTIVE SUMMARY 
 
 
In 2006, prescription drug coverage became available under Medicare for the first 
time. Called Medicare Part D, the program is the most significant change in government 
health care programs in 40 years, offering the potential for improved access to needed 
medications for millions of Americans. 
 
The new program has had success, but has also faced daunting challenges. 
Researchers now have a chance, early in Part D’s second year, to learn from the 
experience to date and to strengthen the program, particularly as it affects the frailest, 
sickest, and most vulnerable beneficiaries, including nursing home residents. 
 
The complexity of the program poses particular challenges for “dual eligibles”—
Medicare beneficiaries who also qualify for Medicaid benefits. These beneficiaries, most of 
whom previously had received drug coverage through Medicaid, were switched to Medicare 
coverage under Part D and auto-assigned to eligible plans beginning January 1, 2006. 
 
Although dual eligibles had the option to switch to a different plan for their drug 
coverage if they preferred, they were not necessarily in a good position to effectively do 
so. In addition to having the lowest incomes, this group disproportionately includes 
beneficiaries with multiple chronic conditions that result in high prescription drug usage: 
dual eligibles average 10 more prescriptions per month than other beneficiaries. They are 
the least-educated group of Medicare beneficiaries and are the most likely to be limited in 
English proficiency. In addition, a disproportionately high percentage of dual eligibles 
have cognitive impairments. 
 
Although 13.2 million beneficiaries are eligible for a low-income subsidy that helps 
pay the premiums for Part D and the copayments for medications, 3.3 million of this group 
are not receiving the subsidy and are not enrolled in Part D. Administrators must find 
better ways to reach out to those beneficiaries, simplify the enrollment process, and assist 
beneficiaries in navigating that process. Better communication and closer monitoring of the 
program’s operations would help enhance its quality and increase its value to beneficiaries. 
 
The implementation of the Part D program was a huge undertaking accomplished 
very quickly. Unlike other benefits available under traditional Medicare, Part D is 
administered through almost 1,900 stand-alone prescription drug plans (PDPs). The 
number of PDP options ranges from 45 to 66, depending on where the beneficiary lives. 
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Part D coverage is also available through more than 1,000 private Medicare Advantage 
Part D plans (MA-PDs) that provide Part A (hospital insurance) and Part B (supplementary 
medical insurance), as well as Part D prescription drug benefits. 
 
Plans differ from each other in design; in costs of premiums, deductibles, and 
coinsurance or copayments; in formulary composition; and in the process for obtaining 
coverage for drugs not included in the formulary. In addition, Part D plans have broad 
discretion, within certain statutorily prescribed parameters, to decide which drugs to 
include in their formularies; the strengths and dosage forms of covered drugs to include; 
and the types of “utilization management processes” used to control drug costs and usages. 
 
To complicate the process even more, a number of entities are involved in the 
administration of the Part D program: The Centers for Medicare and Medicaid Services 
(CMS) administers the Medicare program and has overall responsibility for Part D; the 
Social Security Administration and state Medicaid offices have primary responsibility for 
approving applicants for the low-income subsidy; Part D plans provide the benefits; 
physicians prescribe medications based on plan design; and pharmacies fill the prescriptions. 
 
Under utilization management, plans may establish different copayments for 
different drugs: “tiered pricing” distinguishes among preferred drugs, non-preferred drugs, 
generic drugs, and specialty drugs. Plans may also limit the number of pills or dosage 
amounts; require that beneficiaries request prior authorization for covered prescription 
drugs; or require that they try particular medications included in the plan’s formulary 
before those prescribed by the physician (“step therapy”). 
 
Some evidence suggests that utilization management techniques have caused delays 
or otherwise restricted access to prescription medications, including mental health drugs. 
These techniques have the potential to cause disastrous outcomes in patients⎯particularly 
the most vulnerable. 
 
This report discusses some of the challenges vulnerable Medicare beneficiaries face 
in using Part D and makes specific recommendations to strengthen the program in certain 
areas (box). Legislative authority is needed to accomplish some of these changes, such as 
eliminating or amending the resource test, changing the rules for individuals needing 
long-term care services, and ensuring that funds for counseling are appropriately available. 
Legislative changes would also be useful to ensure that current drug regimens are 
considered when auto-enrollment occurs. In the interim, a different regulatory 
interpretation of certain legal provisions could help. Most of the other changes that are 
needed could be accomplished administratively. 
 vii
 Recommendations to Strengthen Part D Program Areas 
 
The Low-Income Subsidy 
• Eliminate or amend the resource test 
• Provide enrollment encouragement and assistance 
• Monitor redeeming and redetermination 
 
Transition from Medicaid to Medicare 
• Use available information in making plan assignments 
• Simplify the transition process by extending the supply of 
non-formulary drugs 
• Expand the “point-of-service” system 
 
The Use of Formularies and Utilization Management Tools 
• Improve the coverage determination process 
• Use simpler, more standard procedures 
 
Part D and Long-Term Services and Supports 
• Ease the process to get appropriate drugs to nursing home residents 
• Extend protections for nursing home residents to individuals in 
the community 
 
Program Quality 
• Strengthen electronic communication 
• Provide program information in new ways 
• Ensure support for counseling 
 
These beneficiaries are the least able to understand how to pursue an exception 
request or other coverage determination. Some changes to current practices could help 
beneficiaries and those who assist them resolve problems related to the coverage of specific 
drugs. Concerted efforts to inform beneficiaries about the coverage determination process, 
for example, would be helpful, as would standardization of the procedures and criteria 
used in the exceptions and appeals process. 
 
Experience in 2006 suggests additional steps that could be taken to ensure that the 
Part D program operates more effectively. More monitoring on the part of CMS is 
needed, and the government should take steps to strengthen electronic communication 
systems, provide program information in new ways, and ensure that beneficiary counselors 
are available, particularly for the frailest, sickest, and most vulnerable. 
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IMPROVING THE MEDICARE PART D PROGRAM 
FOR THE MOST VULNERABLE BENEFICIARIES 
 
 
BACKGROUND 
The creation of Medicare Part D has provided an opportunity for improved access to 
prescription drugs for many Medicare beneficiaries, particularly for those who previously 
had no drug coverage. Many beneficiaries, however, have encountered numerous, 
significant difficulties as they attempt to enroll in the program or use the benefits it offers. 
The implementation of the Part D program was a huge undertaking accomplished very 
quickly. After a year of experience, researchers have sufficient information to begin 
identifying ways that the program could be made to work better for all beneficiaries. 
 
Unlike other benefits available under traditional Medicare, Part D is administered 
through almost 1,900 stand-alone prescription drug plans (PDPs). The number of PDP 
options ranges from 45 to 66, depending on where the beneficiary lives.1 Beneficiaries also 
have the option of receiving Part D coverage through more than 1,000 private Medicare 
Advantage (MA) plans that provide Part A (hospital insurance), Part B (supplementary medical 
insurance), and Part D (prescription drug) benefits. Plans differ from each other in design; 
in costs of premiums, deductibles, and coinsurance or copayments; in formulary composition; 
and in the process for obtaining coverage for drugs not included in the formulary. 
 
The complexity of the program poses particular challenges for dual eligibles: 
Medicare beneficiaries who also qualify for Medicaid benefits. These beneficiaries, most of 
whom had previously received drug coverage through Medicaid, were automatically 
switched to Medicare coverage under Part D and randomly assigned to an eligible PDP or 
MA plan beginning January 1, 2006. Although dual eligibles had the option to switch to a 
different PDP or MA plan for their drug coverage if they preferred, they were not 
necessarily in a good position to effectively exercise that option. In addition to having the 
lowest incomes, this group disproportionately includes beneficiaries with multiple chronic 
conditions requiring high prescription drug usage: dual eligibles average 10 more 
prescriptions per month than other beneficiaries.2 They are also the least-educated group 
of Medicare beneficiaries and the most likely to be limited in English proficiency.3 In 
addition, a very high percentage of dual eligibles have cognitive impairments.4
 
The early stages of implementation of the Part D benefit involved some major 
difficulties—particularly for dual eligibles—as the Centers for Medicare and Medicaid 
Services (CMS) dealt with a number of operational problems. Most state governments 
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responded to these problems by providing temporary assistance for all or part of 2006 to 
vulnerable Part D beneficiaries who experienced difficulties in obtaining medications, and 
public and private organizations worked tirelessly to reach and counsel such beneficiaries. 
Now is an opportune time, as the prescription drug benefit enters its second year, to 
examine program operations and identify which policy and administrative changes could 
potentially ensure the program works more effectively for dual eligibles and other 
vulnerable Medicare beneficiaries. 
 
THE LOW-INCOME SUBSIDY: STRATEGIES TO INCREASE ACCESS 
The Part D low-income subsidy is a valuable aspect of the Part D program that has the 
potential to help some of the most needy beneficiaries obtain drug coverage.5 The subsidy 
is available to beneficiaries with incomes up to 150 percent of the federal poverty level 
($1,271 per month in 2007) and limited resources, and provides substantial help through 
payments of plan premiums and prescription cost-sharing. Millions of those eligible for the 
LIS, however, are not enrolled or benefiting from it. 
 
The latest estimates released by CMS indicate that 13.2 million beneficiaries are 
eligible for the subsidy. But 3.3 million beneficiaries⎯one-quarter of all who are eligible 
and one-half of those who are eligible but were not automatically enrolled⎯are not 
receiving the subsidy and are not enrolled in a Part D plan (Figure 1).6 The Department 
of Health and Human Services reported in June 2006 that a total of 4.4 million Medicare 
beneficiaries were not enrolled in Part D and had no identified source of creditable 
coverage; the great majority of them⎯about 75 percent⎯appeared to also qualify for the 
subsidy.7 Moreover, other low-income beneficiaries who are enrolled in Part D may not 
be receiving the subsidy for which they might be eligible. 
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Figure 1. CMS Estimates of Eligibility and Participation
in the Medicare Part D Low-Income Subsidy
Full/partial dual 
eligibles and SSI 
recipients 
automatically 
receiving low-
income subsidies 
and enrolled in 
Part D plan
Dual eligibles = 
6.88 million 
(52%)
SSA-determined eligible 
receiving subsidy and 
enrolled in Part D plan = 
2.3 million (17%)
Eligible for subsidy 
and estimated to have 
creditable coverage =
0.72 million (4%)
3.3 million 
(25%)
Eligible but not 
receiving subsidy 
and not enrolled 
in Part D plan*
* Includes future anticipated facilitated enrollment of 0.03 million beneficiaries.       
Source: Centers for Medicare and Medicaid Services, “Medicare Drug Plans Strong and Growing,”
press release (Washington, D.C.: CMS, Jan. 30, 2007).
Beneficiaries Eligible for Low-Income Subsidy = 13.2 Million
 
 
To increase access to the subsidy for those who need it, policymakers could 
consider eliminating or amending the resource test; providing financial and other support 
for programs that assist beneficiaries with the enrollment process; and stepping up 
monitoring efforts to ensure that qualified beneficiaries do not lose their subsidy when it is 
time to re-assess their eligibility. 
 
Eliminate or Amend the Resource Test 
The government’s resource test deters beneficiaries from qualifying for the low-income 
subsidy. A review conducted by the Social Security Administration (SSA) in January 2006 
showed that more than half (57%) of those applying for the subsidy who would have 
qualified based on income were determined ineligible because their resources exceeded 
the eligibility requirement. Bank accounts were the most common source of excess 
resources for these applicants.8 Another recent study corroborates this, indicating that 
most applicants who meet the income but not the resource limits for the low-income 
subsidy have relatively modest assets that tend to be in bank accounts.9 These individuals 
with very low incomes are being penalized because they saved their money, often in 
anticipation of health-related expenses in later life. 
 
In addition to blocking coverage for some very needy beneficiaries, use of a 
resource test increases the complexity of the application process. Applicants may not 
complete the process if they do not understand what is required or cannot produce 
information pertaining to the value of assets such as life insurance policies. The need to 
verify the value of resources also imposes an administrative burden on SSA. 
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Legislation to eliminate the resource test would solve these problems for 
beneficiaries and significantly reduce the administrative burden on SSA. Short of 
elimination, other changes could make the test less onerous and fairer. For example, SSA 
could increase the amount that is disregarded in calculating the value of countable assets. 
Precedent for this exists in the Medicare Savings Programs (MSPs), which help with Part 
B premiums and copayments for other Medicare services. In administering those 
programs, 10 states have established exclusions higher than the standard $1,500 for life 
insurance or burial funds to determine program eligibility.10
 
The treatment of retirement funds also deserves consideration. For the relatively 
small proportion of people with low incomes who have retirement plans, current rules 
favor defined benefit rather than defined contribution plans, because the present value of 
future benefits is not counted as an asset for the former but is for the latter. A more 
equitable approach would be to include the estimated payment from defined contribution 
retirement funds in calculating incomes and not to count retirement funds at all when 
calculating resources. SSA has already demonstrated its willingness to modify rules used by 
the Supplemental Security Income (SSI) program (the link to which is made in the Part D 
statute) by eliminating non-liquid resources, such as automobiles, from its calculations. 
 
At a minimum, SSA should make certain data available so that policymakers can 
assess the impact of the resource test on program participation. It would be helpful, for 
example, if the agency periodically reported the proportion of applicants who qualify for 
the subsidy based on income, but not on resources, and characterized the types and 
amounts of resources reported for that group. 
 
Provide Enrollment Encouragement and Assistance 
Even though the low-income subsidy is an aspect of the Part D program, its application 
process is entirely separate from the Part D plan enrollment process and both are difficult 
to navigate. As a result, some of the most vulnerable beneficiaries have to complete two 
complex processes to benefit from the Part D program. 
 
The fact that millions of eligible beneficiaries do not receive the subsidy suggests 
the need for more efforts to publicize it. The increased availability of information materials, 
applications, and correspondence in languages in addition to English is one recommendation 
frequently made by organizations working in the community. For example. SSA makes 
sample subsidy applications available in 15 languages for information purposes, but only 
has the capacity to accept scannable English and Spanish versions for processing. 
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Also needed are support for one-on-one counseling and the involvement of 
community-based organizations in providing assistance and counseling. Finally, some 
simple changes in procedures could make the application process less daunting. SSA could 
amend the language used on the subsidy application, for example, to eliminate references 
to prison as the penalty for perjury. Language commonly found on other applications 
merely certifies the truth under penalty of perjury, without the unnecessarily threatening 
mention of prison time. 
 
Monitor the Redeeming and Redetermination Processes 
Finally, it is important to consider the processes for reassessing eligibility for the low-
income subsidy.11 Ensuring that the subsidy continues uninterrupted for eligible 
individuals is a significant goal. Otherwise, beneficiaries must reapply for subsidies and 
may have to go without the needed benefit while they wait for re-approval. Some of the 
associated problems that occurred during early implementation of the benefit⎯not 
understanding that a two-part process is required to apply for a subsidy and enroll in a 
plan; random assignment to plans with inappropriate formularies or inaccessible 
pharmacies; long waits for plan cards; and delays in system updates⎯may occur again. If 
such difficulties arise, SSA, CMS, drug plans, and pharmacists will be unnecessarily 
burdened with the need to reconcile subsidy and plan enrollment status. 
 
Eligibility for the low-income subsidy will automatically extend through 
December 2007 for Medicare beneficiaries who were deemed and remain eligible because 
they still qualify for Medicaid, MSPs, SSI, as well as Medicare. CMS, however, notified 
approximately 630,000 beneficiaries that they would not be automatically eligible for the 
subsidy in 2007 because of changes in their Medicaid, MSP, or SSI eligibility status.12 
These individuals⎯who likely are particularly vulnerable considering that they recently 
qualified for one of those benefits⎯have to file a new application for the subsidy. Many of 
these individuals will still qualify for the subsidy. The likelihood that individuals deemed 
eligible will “churn” off and on the subsidy program could be reduced if CMS, before 
terminating benefits, were required to screen individuals losing deemed status for all 
possible subsidy eligibility categories, and if those whose subsidy is terminated had the 
procedural right to appeal the decision. 
 
By law, SSA is required to redetermine eligibility for the low-income subsidy 
within one year of the initial determination. In the fall of 2006, SSA sent letters to 
beneficiaries receiving the subsidy asking them to review information that it had on file for 
them and explaining that if circumstances had not changed, no response was necessary. 
Those beneficiaries for whom circumstances had changed were asked to return a form 
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indicating how their circumstances had changed so that SSA could make a redetermination 
regarding eligibility. In subsequent years, redeterminations will occur at different intervals 
depending on SSA’s assessment of the likelihood that circumstances affecting an 
individual’s eligibility will change.13 SSA has not yet announced what methods will be 
used to establish the intervals. Experience from other programs should be considered. 
Research shows, for example, that a substantial proportion of older low-income Medicare 
beneficiaries remain eligible for MSP benefits year after year.14 In addition, after the first 
and subsequent redeterminations, SSA will be able to track outcomes and base policy on 
that information. The process could be further simplified by eliminating the resource test 
at the time of redetermination. 
 
 
A Missed Opportunity: 
Screening for Low-Income Medicare Beneficiaries 
 
Medicare beneficiaries have the option of applying for the low-income subsidy either 
through SSA or the state Medicaid office. SSA, CMS, and the states, through all their 
outreach and guidance materials on the subsidy, promoted SSA as the place to apply 
for the benefit, despite the statutory requirement that states, not SSA, screen subsidy 
applicants for Medicaid and MSP eligibility. As a result, nearly all applications to date 
have been processed through SSA.15 Few subsidy applicants have been screened for 
Medicaid or MSP. A recent comparison of the subsidy and MSP eligibility and 
enrollment rules indicates that each application site has certain advantages, but 
concludes that applying for the subsidy at the state agency will almost always be more 
beneficial to the applicant because of the screening mandate and because, particularly 
in some states with more liberal MSP eligibility standards, individuals who are not 
otherwise eligible for the subsidy may qualify through the MSPs.16 Federal mandates 
for SSA to screen for Medicaid eligibility or for SSA to forward specific eligibility 
information from the subsidy application to the Medicaid office for review and 
processing could provide additional assistance to very vulnerable Medicare beneficiaries. 
In addition, Medicare beneficiaries who apply for Medicaid benefits but do not qualify 
should have the opportunity to have their Part D and subsidy eligibilities determined 
based on the information they already have provided to Medicaid. 
 
 
EASING THE TRANSITION FROM MEDICAID TO MEDICARE COVERAGE 
Medicaid beneficiaries’ prescription drug coverage automatically shifts to Medicare when 
they became newly eligible for Medicare Part D. In anticipation of this transition, and in 
recognition of the fact that dual eligibles are a vulnerable population whose access to 
prescription drug coverage is essential, the Medicare Modernization Act contains specific 
protections to maintain seamless coverage. The Act directs CMS to assign all dually 
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eligible beneficiaries who do not choose a plan on their own to plans randomly selected 
among the qualifying plans in the beneficiaries’ region.17 The act also provides that dual 
eligibles may switch plans at any time.18 This right to switch plans is important because 
random assignment may result in duals being assigned to plans that do not meet their 
needs.19 An initial large shift from Medicaid to Medicare of more than 6 million dually 
eligible beneficiaries occurred in January 2006. Problems at that time resulted in denied 
access to drugs and interrupted care for many people.20
 
The shift from Medicaid to Medicare coverage is ongoing as Medicaid 
beneficiaries continue to qualify for Medicare. In California alone, tens of thousands of 
Medicaid beneficiaries become eligible for Medicare each month.21 Another reason for a 
change in drug coverage is that beneficiaries who receive the low-income subsidy will be 
annually reassigned to another plan if they are enrolled in plans that have premiums above 
the benchmark established by CMS. Almost 250,000 beneficiaries were affected in this 
way in 2007.22 Reassignment also occurs when dually eligible beneficiaries are enrolled in 
plans that leave the market. 
 
Recommendations to ease some of the difficulties that have been associated with 
the transition process include the use of information to match beneficiaries’ needs with 
plans’ offerings during the auto-enrollment process, simplification of the transition process, 
extension of the time period when initial supplies of non-formulary drugs are available, 
and enhancements to the “point-of-service” system. 
 
Make Beneficiary-Focused, “Random” Part D Plan Assignments 
Random assignment, as it presently occurs, does not take into account beneficiaries’ 
prescribed drugs or pharmacy usage. A different approach could take advantage of the fact 
that Medicaid programs already have information about the particular drugs that 
beneficiaries take. The use of this information to match beneficiaries with Part D plans 
should be considered. Although the statute uses the word “random” with respect to the 
auto-enrollment, CMS could interpret that word to mean random among those plans that 
meet the beneficiary’s needs. In fact, CMS already has approved the use of beneficiary-
centered assignment by at least six state pharmacy assistance programs and one state 
Medicaid program.23 An assignment that is made effective immediately and takes into 
account the individual’s drug and pharmacy usage would substantially reduce the problems 
that dual eligibles faced in 2006 with respect to access to drugs. 
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Auto-Enrollment and Pharmacy Access: 
Special Challenges for Rural Residents 
 
Medicare beneficiaries in rural areas⎯not just those who are dually eligible⎯have 
had trouble finding pharmacies where they live that participate in their Part D plans. 
Current requirements for geographic access in rural areas are only that 70 percent of 
beneficiaries live within 15 miles of a pharmacy.24 This minimal and inadequate 
pharmacy access requirement, together with random auto-enrollment that does not 
take place of residence into account (but which is limited to qualifying plans with 
premiums below the regional benchmark), results in lack of meaningful access to 
pharmacies for some dual eligibles. More stringent geographic participation 
requirements, together with more targeted auto-enrollment, could improve access 
to pharmacies for dual eligibles as well as other Medicare beneficiaries. 
 
 
Extend, Simplify, and Publicize the Transition Process 
Every Medicare Part D drug plan must have a process to address the needs of new 
enrollees who are, at the time of enrollment, using medications not included on the plan’s 
formulary. For 2006, CMS guidance recommended, but did not require, that plans 
provide a temporary 30-day supply of non-formulary medications.25 The purpose of the 
transition supply was to allow beneficiaries time to change to a formulary drug or ask for 
an exception to the formulary exclusion of the drug. Dual eligibles who are randomly 
auto-enrolled in plans are particularly likely to need this type of assistance, since auto-
enrollment does not take into account their specific drug needs. 
 
For 2007, CMS guidance changed the recommendation to a requirement for a 30-
day supply of non-formulary drugs.26 A 30-day period may be an insufficient amount 
time, however, for beneficiaries to obtain prescriptions for alternative medications, work 
with their physicians to determine the efficacy of the new medication, and, if necessary, 
request an exception to receive coverage for the original medication. A longer transition 
time⎯such as 90 days⎯is more appropriate, as suggested by the CMS 2007 guidance for 
transitions for nursing home residents, which requires monthly refills of transition supplies 
through the first 90 days of plan enrollment.27
 
Although beneficiaries had a great need for temporary supplies of medications in 
the early months of the Part D program, the option of requesting initial supplies of non-
formulary drugs generally was not used because information on the various processes 
established by the plans was not readily available, and the processes were confusing and 
difficult to use. Pharmacists indicated that they were advancing enormous quantities of 
prescription medicine and were financially at risk.28 CMS urged plans to voluntarily 
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extend temporary supplies of medications through March 2006,29 and more than 40 states 
stepped in to provide backup emergency assistance for their Medicaid populations.30 Some 
states continue to provide more limited assistance.31
 
The lack of clear information for beneficiaries about what they needed to do after 
receiving a “transition” supply of drugs added to the complexity of using a plan’s 
transition process. Absent clear notice about the next step, some beneficiaries arrived at 
the pharmacy after their transition supply ended to find that their drug would not be paid 
for. Information about the plans’ transition processes is still not readily available.32 If the 
use of a standard transition process were mandated and publicized, beneficiaries and those 
who assist them would be much more likely to be informed, understand the process, and 
ultimately benefit from it. Absent a single process, the transition requirements and 
procedures for each drug plan should be on the CMS’s and plans’ Web sites, and an easily 
understood written summary should be provided to all plan members in a timely manner. 
 
Strengthen and Expand the Point-of-Service System 
In 2005, prior to 2006 auto-enrollment, CMS created a “point-of-service” system to help 
dual eligibles who were not assigned to plans.33 If dual-eligible beneficiaries went to get a 
prescription filled but the pharmacy had no record of plan assignment for them, 
pharmacists might have filled the prescription and billed a point-of-service contractor 
selected by CMS to pay and reconcile claims, but they were not required to do so. 
 
The current point-of-service system could be modified to respond to other 
common problems that arise for dual eligibles at the pharmacy. For example, some duals 
are assigned to more than one plan. Some are improperly charged higher copayments, 
even though they are entitled to minimal cost-sharing, because the information in the 
pharmacy’s computer system is incorrect. In a national survey of pharmacists conducted at 
the end of March 2006, more than half of respondents said they had at least five Part D-
related problems each day.34 When beneficiaries encounter problems at the pharmacy, 
they may not get the drugs they need, they may be overcharged for drugs they receive, or 
pharmacists may provide the drugs but incur financial risk themselves. Two surveys of 
pharmacists indicate that about half reported dispensing prescriptions to Medicare 
beneficiaries before knowing they would be reimbursed.35
 
The point-of-service system could be made mandatory for use by all pharmacists, 
and strengthened to allow, on a temporary basis, prescription coverage for all dual eligibles 
who encounter problems at the pharmacy. For example, once a Medicare beneficiary 
shows evidence of Medicaid coverage or subsidy enrollment, a prescription could be filled 
 9
immediately and billed to the point-of-service contractor. CMS or the point-of-service 
contractor could then determine how to bill the plans so that neither the beneficiaries nor 
the pharmacists would be at financial risk, and dual eligibles would have access to their 
medically necessary drugs. An added advantage to expanding the system would be that the 
extent and severity of some of the difficulties dual eligibles face could be documented and 
addressed more easily if one entity were charged with problem solving. Currently, 
beneficiaries seeking to resolve problems may be advised to contact CMS, SSA, state 
Medicaid offices, and Part D plans. This situation makes it difficult to develop coordinated 
systematic responses to problems. 
 
 
A Source of Confusion: 
The Relationship Between Part D Plan Enrollment 
and the Receipt of Other Medicare Services 
 
Now that beneficiaries must make choices about how they will receive prescription 
drug benefits as well as other Medicare services, the process associated with evaluating 
the risks and benefits of any enrollment choice is much more complex. 
 
The Part D choices are not only a source of confusion, but also of unintended changes 
in coverage for some beneficiaries. Beneficiaries who enroll in a Medicare Advantage 
Part D plan (MA-PD), for example, may not understand that this also necessitates a 
switch from fee-for-service coverage for Parts A and B under traditional Medicare to 
managed care under the private MA-PD plan. Reports explain that insurers offering 
both stand-alone point-of service and MA-PD plans have aggressively marketed their 
MA plans.36 Some beneficiaries may appreciate the opportunity to enroll in an MA 
plan for all of their Medicare services, such as lower cost-sharing, coordinated care, and 
other expanded benefits. Others may not be aware, however, that when they choose 
an MA-PD, they are enrolling in a managed care system that may require them to 
change health care providers. 
 
Low-income beneficiaries already enrolled in MA managed care plans that have 
prescription drug components are automatically enrolled in the MA-PD plan, even if 
their MA-PD has a premium set above the regional low-income benchmark. In that 
case, a low-income MA enrollee could choose to pay the difference between the MA-
PD premium and the low-income subsidy amount, switch plans, or return to 
traditional Medicare. Those who choose to switch plans rather than to pay the higher 
premiums experience a disruption in their existing Medicare coverage for Part A and B 
services since they generally must move to a different network of providers. 
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In addition, the Medicare Modernization Act of 2003 authorized the creation of 
Special Needs Plans (SNPs) to provide specialized care through Medicare Advantage 
plans to certain groups of Medicare beneficiaries: dual eligibles, those with chronic 
illnesses, or those residing in long-term care facilities. Medicaid managed care plan 
sponsors can apply for and receive certification to operate Medicare SNPs. Effective 
January 1, 2006, some Medicare managed care sponsors were permitted to passively 
enroll their Medicaid dual eligibles into their SNPs to receive their Medicare services. 
SNPs were required both to inform beneficiaries that they had been passively enrolled 
into a different type of plan and to offer them the option to disenroll. Some 
beneficiaries, however, did not understand that their Medicare coverage may have 
changed even though they did not request it.37
 
 
STEPS TO IMPROVE THE USE OF FORMULARIES AND UTILIZATION 
MANAGEMENT TOOLS 
Part D plans have broad discretion, within certain statutorily prescribed parameters, to 
decide which drugs to include in their formularies; the strengths and dosage forms of 
covered drugs to include; and the types of “utilization management processes” used to 
control drug costs and usages. Under utilization management, plans may establish different 
copayments for different drugs: “tiered pricing” distinguishes among preferred drugs, non-
preferred drugs, generic drugs, and specialty drugs. Plans may also limit the number of pills 
or dosage amounts; require that beneficiaries request prior authorization for covered 
prescription drugs; or require that they try particular medications included in the plan’s 
formulary before those prescribed by the physician (“step therapy”). Some evidence 
suggests that utilization management techniques have caused delays or otherwise restricted 
access to prescription medications, including mental health drugs.38 These blocks have the 
potential to cause disastrous outcomes for beneficiaries. 
 
All Part D drug plan sponsors must establish a coverage determination process 
through which a plan enrollee may challenge formulary restrictions or other decisions 
about drug coverage made by the Part D plan. An exception request⎯a common type of 
coverage determination⎯is the initial step used to ask the plan to cover a drug that is not 
on the formulary or to request exceptions to rules associated with utilization management. 
After an unfavorable coverage decision, an enrollee may proceed through five levels of 
appeal: redetermination by the drug plan; reconsideration by the independent review 
entity; hearing before an administrative law judge; Medicare Appeals Council review; and 
finally, appeal to federal court. The processes for requesting coverage determinations and 
appeals are complex: they require that enrollees act proactively and provide substantial 
amounts of evidence through all levels of review. 
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All Medicare beneficiaries are affected by plans’ formularies and utilization 
management rules, but beneficiaries who take multiple prescription drugs are less likely 
than healthier beneficiaries to find plans with formularies that cover all of their current 
regimens and therefore are more likely to have to request exceptions. Dually eligible 
beneficiaries who have been auto-enrolled in plans are among the least healthy 
beneficiaries and also among those most likely to need an exception to ensure continuous 
access to all of the drugs that have been prescribed for them. The most vulnerable are 
among the beneficiaries least able to understand how to pursue an exception request or 
other coverage determination. 
 
Dramatic changes are needed to current practices to help beneficiaries and those 
who assist them resolve problems related to the coverage of specific drugs. Concerted 
efforts to inform beneficiaries about the coverage determination process would be helpful, 
for example, as would some standardization of the procedures and criteria used in the 
exceptions and appeals process. 
 
 
Formularies: New Restrictions for Dual Eligibles 
 
The switch from Medicaid to Medicare Part D coverage may pose difficulties related to 
plan formularies for dually eligible beneficiaries. One potential problem is that Part D 
formularies can be considerably more restrictive than Medicaid program formularies. 
An early report indicated that nearly one-third of dual eligibles were assigned to drug 
plans that included less than 85 percent of the 178 most commonly used Part D drugs.39
 
Another difficulty is that Part D plans are permitted to change their formularies during 
a plan year; they are required only to give 60-days notice to those affected by the 
change. CMS directs plans to maintain coverage for existing users for the remainder of 
the plan year.40
 
The cost management tools associated with formularies can be problematic. The 
Alzheimer’s Association reports, for example, that three plans⎯with 8 percent of the 
market share for total enrollment⎯required prior authorization for all FDA-approved 
medications for Alzheimer’s disease.41 (Subsequently, the three plans removed their 
prior authorization requirements for Alzheimer’s drugs.) CMS’s guidance allows plans 
to have prior authorization or other restrictions even for the drugs in the six protected 
categories, under which plans must cover all or substantially all drugs42 The plans 
available for auto-enrollment have a higher percentage of such restrictions than 
other plans.43
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Finally, it is important to note that under Part D, most dual eligibles are subject to 
copayments of between $1.00 and $5.35 (in 2007). Although policymakers usually 
describe the amount of the copayments as “nominal,” monthly expenses can be 
substantial for low-income individuals who take many medications. And, dual-eligible 
beneficiaries have lost an important protection that they had under Medicaid: the 
requirement that pharmacists fill prescriptions even if the beneficiary is unable to make 
the copayment. 
 
 
Improve the Coverage Determination Process 
Current methods to inform enrollees about exception and appeals processes are 
not adequate. 
 
To gain access to the drugs they need, plan enrollees must first know they have a 
right to request an exception or to appeal a coverage decision, and therefore must 
understand the process. Plans are required to describe coverage determination and appeal 
rights and procedures in the “welcome package” or evidence-of-coverage documents sent 
to beneficiaries upon their enrollment, but plans have 30 days from enrollment to provide 
this information. Thus, new enrollees may have difficulty seeking exceptions or other 
coverage determinations in the first month of coverage. A requirement for plans to 
provide information more quickly is necessary. 
 
Generally, beneficiaries first learn they have a coverage problem when their 
request to fill a prescription is denied at the pharmacy. Plans are required to ensure that 
pharmacies post or distribute generic notices of the beneficiary’s right to contact the plan 
to seek an exception, but there is little monitoring of pharmacy compliance with this 
requirement, and the notices themselves are unremarkable. Thus, a beneficiary may leave 
the pharmacy without knowing they have a course of action to remedy the denial or 
without knowing what the course of action is. Plan-specific notices describing the denial 
and subsequent appeal rights could be provided electronically at the pharmacy so that 
beneficiaries would not have to contact the drug plan for this information before any 
action can be taken. Within current statutory and regulatory parameters, each plan 
establishes its own criteria for making coverage determinations. If the criteria used to make 
coverage and appeals determinations were uniform and widely publicized, beneficiaries 
and those who assist them would be better able to pursue appeal rights. 
 
The time that beneficiaries must wait for coverage determinations also has been 
problematic. All Part D plans are required to have a process for making timely coverage 
determinations: they must issue a written decision within 72 hours for a standard request 
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and within 24 hours for an expedited request.44 CMS, recognizing that plans were not 
always adhering to these required timeframes⎯some were making determinations within 
24 business hours (3 days) or even 72 business hours (9 days) repeatedly issued clarifying 
guidance to plans. Reports of delays persist, however, suggesting a need for additional 
monitoring and enforcement of plan compliance with the requirement.45
 
Use Simpler, More Standard Procedures 
Currently, each plan devises its own forms, processes, standards of medical necessity, 
criteria for reviewing requests for exceptions, and other coverage determinations. 
Problems with these determinations occurred frequently during the early months of Part 
D implementation. Beneficiaries and their physicians had difficulty getting information 
about plan processes and could not get through to appropriate plan representatives by 
telephone to make coverage requests. In response to this lack of information, CMS posted 
specific appeals contact information for each Part D plan on its Web site. Still, the burden 
on many medical practices is enormous, especially considering that in most parts of the 
country each practice had to be familiar with forms for more than 40 different stand-alone 
prescription drug plans, plus multiple MA-PDs (Figure 2).46 Each plan not only has its 
own form to request an exception; some have different forms for different classes or 
categories of drugs. Plans that require specific forms do not make them readily available on 
their Web sites or through their call centers. 
 
Figure 2. Doctors’ Assessment of
the Part D Administrative Burden
Overall, would you say that helping patients make decisions about the new
Medicare drug plans and helping them get their drugs under the plans has placed
a lot of burden on you and your staff, some burden, not too much, or no burden at all?
Source: Kaiser Family Foundation National Survey of Physicians (Menlo Park, Calif.: Henry J. Kaiser Family
Foundation, Sept. 2006); N = 834.
A lot of burden
27%
Some burden
37%
Not too
much burden
21%
No burden
12%
Don't know/Refused
3%
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An important first step toward standardization occurred early in 2006, when 
medical and consumer organizations worked with a health plan trade association to 
develop a model form for requesting coverage determinations. The form is available on 
the CMS Web site as well as on the Web sites of many of the largest Part D plans.47 It is 
too early to determine how widespread the use of the form is, but a recent survey of 
medical directors in long-term care facilities showed that only 18 percent said the majority 
of drug plans they deal with are using the common form.48 While use of the form is 
voluntary for the plans, CMS has directed that plans must accept any written request 
(including the standard form) for an exception or other coverage determination. 
 
More standardization of the process and criteria plans use for exceptions and 
appeals would be helpful. At the pharmacy, the most logical and efficient approach from 
the perspective of consumers would be to treat the denial of coverage at the pharmacy 
as the coverage determination, and then to give beneficiaries standard instructions 
regarding the next steps in the appeals process. For physicians, the process could be 
improved considerably if a uniform definition of medical necessity and the standards for 
proving the need for a particular medication were articulated. Currently, the amount and 
type of supporting documentation requested from physicians by some drug plans is 
problematic. In addition to the supporting statement, doctors have been asked to submit 
all clinical records for the enrollee. Plans also have required that evidence from peer-
reviewed medical journals be submitted. It is important to note that Medicare does not 
compensate physicians for the time spent in seeking or supporting an exception request. 
And, if changes in drug regimens do occur because of formulary restrictions, Medicare 
may have to pay for several office visits to monitor the efficacy of the new drug for the 
beneficiary. In a survey of medical directors working in long-term care facilities, more 
than half (55 percent) reported frequent problems with requests for exceptions for drugs. 
Despite language in the statute indicating that physicians’ statements are appropriate 
support for formulary exceptions and language in guidance giving such statements “great 
weight,” the Part D appeal regulations explicitly direct that physicians’ opinions do not 
control determinations about requests for exceptions.49 As a result, financial rather than 
medical considerations may be the basis for changes in treatments that have been working 
effectively for many years. 
 
PART D AND LONG-TERM SERVICES AND SUPPORTS 
Advocates, the nursing home industry, and the long-term care pharmacy industry are 
watching to determine how Part D is affecting Medicare beneficiaries who need long-
term services and supports. 
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Ease the Process to Get Appropriate Drugs to Nursing Home Residents 
Physicians and pharmacists who provide care and services to nursing home residents report 
that drugs on plan formularies are not always appropriate for the frail, disabled, and 
debilitated nursing home population. Physicians report problems with formulary drugs 
that are frequently inappropriate for their patients, and CMS guidance recommends that 
these drugs not be used for nursing home residents at all or only with great caution.50 
Some physicians report that prescribing any medication other than a generic drug meets 
with plan resistance. Residents whose complex drug regimens have been carefully adjusted 
over the years face tremendous problems with formulary limitations. Almost one-quarter 
of physicians polled who provide long-term care reported problems obtaining drugs for 
patients with Alzheimer’s disease.51
 
Dual-eligible beneficiaries, who comprise a large portion of nursing home 
residents, face additional difficulties. Those who do not choose a plan are automatically 
enrolled, but random assignment to plans does not take into account whether a plan 
covers a beneficiary’s prescriptions in its formulary or includes the facility’s pharmacy in its 
network. As a consequence, the long-term care pharmacy that serves their nursing facility 
may not be participating in the Part D plans to which some residents are assigned. Surveys 
of physicians working in the area of long-term care show that although some 
improvement has occurred over time, many have significant difficulty obtaining drugs for 
their patients (Figure 3). Many plans require physicians to call plans personally to support 
exceptions requests; physicians spend an average of 25 to 45 minutes on each call.52 
Physicians are unlikely to maintain these levels of effort indefinitely. 
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Figure 3. Long-Term Care Physicians’ Experience with Part D
44
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70
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Aug-06
Source: American Medical Directors Association Survey of Long-Term Care Physicians, conducted 
May 2006 (N = 441) and Aug. 2006 (N = 237).
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Choosing Plans: 
A Particular Problem for Beneficiaries with Cognitive Impairments 
 
Among Medicare beneficiaries who receive long-term care services, the proportion 
with cognitive impairments is substantial.53 Many of these beneficiaries are unable to 
express concerns about the quality of care they receive or the financial arrangements 
that govern their care. Like all dually eligible beneficiaries, nursing home residents are 
entitled to change Part D plans at any time, but those with cognitive impairments are 
unable to make these decisions themselves, and thus cannot choose a plan initially or 
disenroll from a plan that is not covering all their drugs and then choose a new plan. 
Furthermore, most nursing home residents have not been adjudicated incompetent and 
do not have guardians who can act on their behalf. Although many state laws authorize 
surrogate decision-making related to health care, Part D is a new benefit, and because 
the issue is not addressed in statute or regulation, it is unclear whether choosing a plan 
is a health care decision or a financial insurance decision. This problem makes applying 
state law difficult. Federal law should be clarified to allow family members to assist 
beneficiaries with enrolling, disenrolling, and pursuing appeals, even if they do not 
have an official appointment of representative authorization from the beneficiary. 
 
 
 17
Extend Protections to All Beneficiaries Needing Long-Term Services 
The provision of Medicaid-financed long-term services in community-based settings 
rather than in nursing facilities or other institutions has been promoted by states and the 
federal government and is preferred by many beneficiaries. Much existing public policy 
favors offering this choice, yet the Medicare Part D copayment rules may make the option 
of living in the community difficult for many dually eligible people. 
 
Under Medicaid rules, beneficiaries in nursing facilities or other institutions and in 
home and community-based settings⎯including assisted living and board-and-care 
facilities⎯can keep only a small amount of money, generally $35 to $50 per month, for 
personal needs such as clothing or toiletries.54 Despite their lack of available income, 
beneficiaries in the community have cost-sharing obligations under Part D for their 
drugs.55 They must make copayments for prescription drugs that are covered by their Part 
D plan. In addition, they must pay for any prescription drugs not covered by their plan’s 
formulary (unless they successfully win an exception or appeal), for prescription drugs that 
are excluded from coverage under Part D by the Medicare Modernization Act, and for 
over-the-counter drugs. They also may be required to pay full price for a non-formulary 
drug while pursuing an exception. 
 
Dually eligible residents of nursing homes and other institutions, however, are not 
required to make any copayments under Part D.56 Moreover, dual eligibles in nursing 
homes do not have to pay for over-the-counter drugs,57 and the federal Nursing Home 
Reform Law requires nursing facilities to provide them with all drugs that are required by 
their physicians, even if there is no source of payment for those drugs.58 CMS guidance 
directs plans to provide a supply of non-formulary drugs to residents of institutions 
pending the outcome of a request for a formulary exception.59,60
 
Depending on their drug needs and the coverage provided by their Part D plans, 
beneficiaries in community-based settings may have significant monthly drug costs that 
they cannot afford. This expense could be one factor that influences a beneficiary’s choice 
to move to a nursing facility rather than stay in the community. Eliminating the disparity 
in copayments by applying the nursing home copayment rule to individuals receiving 
community-based long-term care services would assist in alleviating this problem. 
 
A source of assistance for dual eligibles in nursing homes and in certain 
community-based settings to pay for copayments as well as for non-covered drugs is 
Medicaid’s incurred medical expense deduction. This required deduction allows a 
beneficiary to deduct such expenses from his or her income before paying most of the 
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remainder of the income to the provider of services. This benefit is not well publicized, 
however, and having good information about this benefit and how to use it in their states 
would enhance beneficiaries’ lives.61
 
EFFORTS TO IMPROVE PROGRAM QUALITY 
Experience in 2006 suggests that certain steps could be taken to ensure that the Part D 
program operates more effectively. As noted above, more monitoring on the part of CMS 
is needed, as is government-supported strengthening of electronic communication systems. 
In addition, efforts are needed to provide program information in new ways and to ensure 
that beneficiary counselors continue to be available. 
 
Strengthen Electronic Communication 
A number of entities are involved in the administration of the Part D program: CMS 
administers the Medicare program and has overall responsibility for Part D; SSA and state 
Medicaid offices have primary responsibility for enrolling applicants into the low-income 
subsidy; Part D plans provide the benefits; and pharmacies fill prescriptions. CMS has 
established systems to convey information electronically about beneficiaries’ plan affiliation 
and subsidy status, but difficulties arise when the information in the system is incorrect, 
not current, or when its transmission is infrequent. 
 
Pharmacists are accustomed to working with computer systems that function in 
“real-time,” and the slower Part D system can be problematic. For example, dual eligibles 
may switch plans anytime during a month and new coverage should be effective the first 
of the following month. If the electronic switch has not been fully processed by then, 
however, beneficiaries may be unable to obtain medication from their new plan when 
they go to the pharmacy. 
 
In addition, information about the subsidy status of the beneficiary is often not 
available to the pharmacist in a timely manner. As a result, dual eligibles are incorrectly 
charged copayments applicable to the general Medicare population62 that are unaffordable 
to them.63 A logical solution would be to develop a single system that allows information 
about plan enrollments, disenrollments, and subsidy status to appear in the computer 
system nationwide within minutes of a change rather than after days, weeks, or months. 
 
Provide Program Information in New Ways 
Some beneficiaries have had difficulty obtaining accurate, detailed information about the 
Part D program in a timely manner. Notices sent to beneficiaries by Part D plans have also 
been a source of confusion, particularly when generic notices⎯such as notices about 
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required copayments⎯are sent to all beneficiaries, but may apply only to some of them. 
Beneficiaries seek information from physicians and pharmacists, who traditionally are 
trusted sources of information, but these professionals often do not have access to all of the 
information they need to help. The medicare.gov Web site is remarkable for the amount 
of material presented, but it is difficult to use. Also, many beneficiaries do not have access 
to the Internet or do not know how to use it.64,65
 
The provision of more general information on paper about the program, the plans, 
and how to choose, enroll in, and use a plan would be helpful. Similarly, beneficiaries and 
those who assist them need information about applying for and using the low-income 
subsidy and instructions about how to request a coverage determination or file an appeal. 
Easy-to-read written materials in multiple languages are also badly needed. Notices and 
information should be sent regularly to beneficiaries at a literacy level appropriate to them 
and in a language they can read. This provision may require additional resources for the 
development and enforcement of standards regarding literacy level and translations. 
 
The national toll-free Medicare number (1-800-MEDICARE) is available for 
answering questions, but accessibility continues to be a major problem and counselors do 
not always provide accurate information.66 One possible means of expanding and 
improving Medicare’s customer assistance, information, and problem-solving capacity is to 
train personnel in various areas of expertise so that calls from beneficiaries, plans, 
pharmacies, and advocates, all of whom have different issues and needs, can be answered 
effectively. In addition, staffing levels should be appropriate, and the competency of all 
operators or counselors should be evaluated before they serve customers. CMS should use 
its enforcement authority to monitor how plans provide customer information and to 
sanction plans that do not comply with appropriate standards. In addition, Congress 
should monitor and evaluate CMS to ensure the quality of its materials, customer service, 
and information functions. 
 
Ensure Support for Counseling 
Some of the issues that confused beneficiaries at the initial implementation of Part D have 
been addressed; others remain unresolved. The need for more and ongoing assistance is 
anticipated as Part D plans enter and exit the market for the second year of the program; as 
they make changes to their formularies, cost-sharing requirements, and other policies and 
procedures; and as recertification for the LIS is required. 
 
By necessity, much of the counseling and problem-solving to date has occurred on 
a one-to-one basis, but this is a difficult level of effort to sustain. State Pharmaceutical 
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Assistance Programs, which existed in many states prior to the Part D benefit and are still 
active in about 20 states, have been helpful in counseling beneficiaries and, in some 
instances, in enrolling them in plans to coordinate with state benefits.67 The State Health 
Insurance Assistance Programs (SHIPs) in each state have been funded to counsel all 
Medicare beneficiaries but have been overwhelmed by the demand for assistance. Federal 
funding for the SHIP program increased from $12.5 million in 2003 to $31.7 million in 
2005, and in both 2006 and 2007 to about $30 million. This amount represents about 
$0.70 per Medicare beneficiary; the SHIP community estimates that $1 per beneficiary 
is needed.68 One-on-one counseling is often essential but not always available.69 
Populations with limited-English proficiency and disabilities have special needs, and 
funding for community-based organizations to provide one-on-one counseling to these 
groups is needed. 
 
CONCLUSION 
The Medicare Part D Program provides valuable new prescription drug assistance to 
millions of beneficiaries. Satisfaction among enrollees is reportedly high, yet a substantial 
portion of eligible beneficiaries is not enrolled. More than 3 million are low-income 
beneficiaries who qualify for programs subsidies. This high figure suggests that efforts to 
publicize the subsidies, simplify enrollment, and assist beneficiaries are needed. 
 
For those who are enrolled, program changes to smooth transitions from Medicaid 
to Medicare and to make the rules associated with obtaining prescription drugs simpler 
and more explicit would be helpful. After a year of experience, program refinements such 
as strengthening electronic data transfers, monitoring plan operations more closely, and 
developing more effective ways of communicating information would help ensure 
program quality for all beneficiaries, and particularly for the frailest, sickest, and most 
vulnerable. These changes should be made to enhance the performance of Medicare Part 
D and increase its usefulness in accomplishing the purpose for which it was intended: to 
provide access to needed health care for the elderly and disabled. 
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Recommendations to Strengthen Part D Program Areas 
 
The Low-Income Subsidy 
• Eliminate or amend the resource test 
• Provide enrollment encouragement and assistance 
• Monitor redeeming and redetermination 
 
Transition from Medicaid to Medicare 
• Use available information in making plan assignments 
• Simplify the transition process by extending the supply of 
non-formulary drugs 
• Expand the “point-of-service” system 
 
The Use of Formularies and Utilization Management Tools 
• Improve the coverage determination process 
• Use simpler, more standard procedures 
 
Part D and Long-Term Services and Supports 
• Ease the process to get appropriate drugs to nursing home residents 
• Extend protections for nursing home residents to individuals in 
the community 
 
Program Quality 
• Strengthen electronic communication 
• Provide program information in new ways 
• Ensure support for counseling 
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